X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ACTAVIS (US) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   ACTAVIS
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
ACTAVIS
Dec-14
ALEMBIC LTD/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs5318,553-   
Low Rs2911,317-   
Sales per share (Unadj.) Rs4.73,340.9-  
Earnings per share (Unadj.) Rs8.8-416.9-  
Cash flow per share (Unadj.) Rs9.0306.5-  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.77,246.3-  
Shares outstanding (eoy) m267.03265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.74.5 194.6%   
Avg P/E ratio x4.7-35.8 -13.1%  
P/CF ratio (eoy) x4.648.7 9.4%  
Price / Book Value ratio x1.52.1 71.8%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,9623,971,215 0.3%   
No. of employees `000NA21.6 0.0%   
Total wages/salary Rs m2380-   
Avg. sales/employee Rs ThNM41,127.2-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-5,132.2-  
INCOME DATA
Net Sales Rs m1,260888,347 0.1%  
Other income Rs m264-2,217 -11.9%   
Total revenues Rs m1,524886,129 0.2%   
Gross profit Rs m83114,121 0.1%  
Depreciation Rs m61192,359 0.0%   
Interest Rs m028,020 0.0%   
Profit before tax Rs m285-108,476 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32-7,957 0.4%   
Tax Rs m6-5,577 -0.1%   
Profit after tax Rs m2,343-110,856 -2.1%  
Gross profit margin %6.612.8 51.1%  
Effective tax rate %2.15.1 41.6%   
Net profit margin %185.9-12.5 -1,489.6%  
BALANCE SHEET DATA
Current assets Rs m1,689468,045 0.4%   
Current liabilities Rs m486341,342 0.1%   
Net working cap to sales %95.414.3 669.0%  
Current ratio x3.51.4 253.3%  
Inventory Days Days21758 373.9%  
Debtors Days Days8166 122.3%  
Net fixed assets Rs m1,624108,476 1.5%   
Share capital Rs m5340-   
"Free" reserves Rs m5,9600-   
Net worth Rs m7,4041,926,791 0.4%   
Long term debt Rs m1041,009,676 0.0%   
Total assets Rs m8,0103,531,174 0.2%  
Interest coverage x950.7-2.9 -33,108.6%   
Debt to equity ratio x00.5 2.7%  
Sales to assets ratio x0.20.3 62.5%   
Return on assets %29.3-2.3 -1,246.9%  
Return on equity %31.6-5.8 -550.0%  
Return on capital %31.3-3.0 -1,039.2%  
Exports to sales %2.90-   
Imports to sales %28.90-   
Net fx Rs m-3280-   
CASH FLOW
From Operations Rs m346152,546 0.2%  
From Investments Rs m-48-365,255 0.0%  
From Financial Activity Rs m-301205,220 -0.1%  
Net Cashflow Rs m-3-7,488 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 68.01 Rs / USD

Compare ALEMBIC LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ALEMBIC LTD With: SUVEN LIFE  PANACEA BIOTECH  J.B.CHEMICALS  DR. REDDYS LAB  WOCKHARDT LTD.  



Today's Market

Sensex Ends 262 Points Lower; Metal & Realty Stocks Fall(Closing)

Indian share markets ended lower today amid weak global cues. At the closing bell, the BSE Sensex finished lower by 262 points.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jun 19, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS